NYMC Faculty Publications
Consensus Panel's Assessment and Recommendations on the Use of 3 Botulinum Toxin Type A Products in Facial Aesthetics
Author Type(s)
Faculty
DOI
10.1177/1090820X13480479
Journal Title
Aesthetic Surgery Journal
First Page
35
Last Page
35
Document Type
Article
Publication Date
3-1-2013
Department
Otolaryngology
Keywords
Botulinum Toxins, Type A, Face, Humans, Rejuvenation, Skin Aging
Disciplines
Medicine and Health Sciences | Otolaryngology
Abstract
In this summary article, the authors discuss the characteristics of abobotulinumtoxinA, incobotulinumtoxinA, and onabotulinumtoxinA. With 3 neuromodulators available in the US market, comparisons between and among products will invariably be made, so arguments for the most effective facial aesthetic uses of each neuromodulator are presented. Topics addressed in this article include patient expectations, toxin reconstitution and preparation, patient positioning, differences among products, the role of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area.
Recommended Citation
Lorenc, Z., Kenkel, J., Fagien, S., Hirmand, H., Nestor, M., Sclafani, A., Sykes, J., & Waldorf, H. (2013). Consensus Panel's Assessment and Recommendations on the Use of 3 Botulinum Toxin Type A Products in Facial Aesthetics. Aesthetic Surgery Journal, 33 (1 Suppl), 35-35. https://doi.org/10.1177/1090820X13480479
